Please login or sign up to post and edit reviews.
Babbage: Going antiviral
Publisher |
The Economist
Media Type |
audio
Categories Via RSS |
News
News & Politics
Tech News
Publication Date |
Nov 09, 2021
Episode Duration |
00:26:15

As covid-19 threatens Europe once again, effective oral antiviral treatments for covid-19 are finally being approved by regulators. Is this the next step towards beating the virus? Also, author Azeem Azhar on what the accelerating growth of technology means for business, the economy and society. And we reveal the winners of our latest book giveaway. Kenneth Cukier hosts. 

For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.

Terms and conditions for the book competition featured in this podcast are available at economist.com/podcast-contest.


Hosted on Acast. See acast.com/privacy for more information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review